| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1027841A |
| P356 | DOI | 10.1371/JOURNAL.PONE.0127841 |
| P932 | PMC publication ID | 4476707 |
| P698 | PubMed publication ID | 26098947 |
| P5875 | ResearchGate publication ID | 279847229 |
| P50 | author | Mark Borris Docdoc Aldonza | Q42369203 |
| P2093 | author name string | Ji-Young Hong | |
| Sang Kook Lee | |||
| Seung Ho Lee | |||
| Song Yi Bae | |||
| Yoonho Shin | |||
| Jayoung Song | |||
| Jedo Oh | |||
| Won Kyung Kim | |||
| P2860 | cites work | Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species | Q43560185 |
| Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells | Q44311673 | ||
| Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats | Q44841876 | ||
| Analysis of cell cycle by flow cytometry | Q44954209 | ||
| Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant. | Q54514341 | ||
| Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax | Q80856775 | ||
| Anti-inflammatory activity of 21(alpha, beta)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque | Q34657489 | ||
| Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer | Q34675534 | ||
| Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Q34983061 | ||
| Role of P-glycoprotein in pharmacokinetics: clinical implications | Q35029495 | ||
| Stable differences in intrinsic mitochondrial membrane potential of tumor cell subpopulations reflect phenotypic heterogeneity | Q35094399 | ||
| Natural products as sources of new drugs over the period 1981-2002. | Q35184693 | ||
| p38α mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway | Q35710005 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Predicted mechanisms of resistance to mTOR inhibitors | Q36585744 | ||
| ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells | Q36625600 | ||
| Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment | Q36844334 | ||
| Redox regulation of cell survival | Q37181226 | ||
| Targeting phosphoinositide 3-kinase signalling in lung cancer | Q37840655 | ||
| Triterpenoids for cancer prevention and treatment: current status and future prospects | Q37861772 | ||
| AMPK: a contextual oncogene or tumor suppressor? | Q38104227 | ||
| Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC. | Q38140353 | ||
| Autophagy and transporter-based multi-drug resistance | Q38202874 | ||
| Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer | Q38215087 | ||
| Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism | Q38308355 | ||
| Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells | Q38987856 | ||
| Role of the highly structured 5'-end region of MDR1 mRNA in P-glycoprotein expression | Q39253389 | ||
| Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells | Q39436728 | ||
| Evaluation of cucurbitane-type triterpenoids from Momordica balsamina on P-glycoprotein (ABCB1) by flow cytometry and real-time fluorometry | Q39482722 | ||
| 25-Methoxyhispidol A, a novel triterpenoid of Poncirus trifoliata, inhibits cell growth via the modulation of EGFR/c-Src signaling pathway in MDA-MB-231 human breast cancer cells | Q39502140 | ||
| A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways | Q39582203 | ||
| Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells | Q39730373 | ||
| Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines | Q39832791 | ||
| 21-Methylmelianodiols from Poncirus trifoliata as inhibitors of interleukin-5 bioactivity in Pro-B cells | Q39981590 | ||
| Screening of potential chemopreventive compounds from Poncirus trifoliata Raf. | Q40223772 | ||
| LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance | Q40225742 | ||
| Anti-inflammatory effect of Poncirus trifoliata fruit through inhibition of NF-kappaB activation in mast cells | Q40297938 | ||
| Activation of ERK or inhibition of JNK ameliorates H(2)O(2) cytotoxicity in mouse renal proximal tubule cells | Q40566533 | ||
| Requirement for ERK activation in cisplatin-induced apoptosis | Q40854460 | ||
| Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin | Q40951146 | ||
| Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123 | Q41606221 | ||
| Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways? | Q41786663 | ||
| Antianaphylactic activity of Poncirus trifoliata fruit extract | Q42527838 | ||
| Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis | Q42601114 | ||
| Modulation of P-glycoprotein ATPase activity by some phytoconstituents | Q43298905 | ||
| Overcoming cisplatin resistance by mTOR inhibitor in lung cancer | Q24815638 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Cancer statistics, 2008 | Q27860585 | ||
| P-glycoproteins and multidrug resistance | Q28285546 | ||
| Cross-talk between signalling pathways and the multidrug resistant protein MDR-1 | Q28364226 | ||
| MAP kinase signalling pathways in cancer | Q29615542 | ||
| mTOR regulation of autophagy | Q29616301 | ||
| Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein | Q31030101 | ||
| Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC). | Q33877902 | ||
| A family of drug transporters: the multidrug resistance-associated proteins. | Q34004952 | ||
| Epidermal growth factor receptor: mechanisms of activation and signalling. | Q34185055 | ||
| 7-Ketocholesterol induces P-glycoprotein through PI3K/mTOR signaling in hepatoma cells | Q34185571 | ||
| Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? | Q34190195 | ||
| P-glycoprotein: from genomics to mechanism. | Q34272173 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | e0127841 | |
| P577 | publication date | 2015-06-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells | |
| P478 | volume | 10 |
| Q92633975 | Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer |
| Q42369142 | Correction: Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells |
| Q95839654 | Decreased expression of FBXW7 by ERK1/2 activation in drug-resistant cancer cells confers transcriptional activation of MDR1 by suppression of ubiquitin degradation of HSF1 |
| Q48522177 | Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway |
| Q36953023 | Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway |
| Q37716565 | L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma |
| Q37376285 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation |
| Q37624466 | Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation |
| Q38806888 | Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells. |
| Q50847783 | TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance. |
| Q42244820 | Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death. |
| Q90729001 | The hippo pathway provides novel insights into lung cancer and mesothelioma treatment |
| Q39152624 | The role of exosomes and miRNAs in drug-resistance of cancer cells. |
Search more.